Status:
UNKNOWN
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.
Lead Sponsor:
Sohag University
Conditions:
Hepatitis B, Chronic
Eligibility:
All Genders
20-70 years
Brief Summary
Find a possible association between Fibronectin type Ⅲ domain containing protein 5 \\ Irsin (FNDC5 rs3480) gene single nucleotide polymorphism with chronic hepatitis B and the distribution of its alle...
Detailed Description
Hepatitis B virus (HBV) infection is a serious public health problem worldwide, with approximately 2 billion people having a history of HBV infection and 350 million of them suffering from chronic HBV...
Eligibility Criteria
Inclusion
- patients diagnosed as a clinical disease of CHB according to the diagnostic criteria of CHB based on, HBsAg, HBeAg serostatus ,HBV DNA level, biochemical liver function, and ultrasonography
Exclusion
- The chronic HBV patients on antiviral therapy will be excluded.
Key Trial Info
Start Date :
July 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06023745
Start Date
July 20 2023
End Date
September 1 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt